Sage Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SAGE and buy or sell other stocks, ETFs, and their options commission-free!About SAGE
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain.
CEOBarry E. Greene, MD
CEOBarry E. Greene, MD
Employees353
Employees353
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees353
Employees353
SAGE Key Statistics
Market cap543.61M
Market cap543.61M
Price-Earnings ratio-1.77
Price-Earnings ratio-1.77
Dividend yield—
Dividend yield—
Average volume3.47M
Average volume3.47M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$9.36
52 Week high$9.36
52 Week low$4.62
52 Week low$4.62
Stock Snapshot
As of today, Sage Therapeutics(SAGE) shares are valued at $8.68. The company's market cap stands at 543.61M, with a P/E ratio of -1.77.
Sage Therapeutics(SAGE) stock opened on 2025-12-17 at —. The price climbed to — and dipped to —.
Sage Therapeutics(SAGE) shares are trading with a volume of 0, against a daily average of 3.47M.
In the last year, Sage Therapeutics(SAGE) shares hit a 52-week high of $9.36 and a 52-week low of $4.62.
In the last year, Sage Therapeutics(SAGE) shares hit a 52-week high of $9.36 and a 52-week low of $4.62.
People also own
Based on the portfolios of people who own SAGE. This list is generated using Robinhood data, and it’s not a recommendation.